You just read:

Canagliflozin Provided Sustained Glycemic Improvements as Monotherapy and in Add-on Combinations in Adults With Type 2 Diabetes in Five Phase 3 Clinical Studies

News provided by

Janssen

09 Jun, 2012, 15:00 BST